These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 16198557

  • 1. Acteoside and martynoside exhibit estrogenic/antiestrogenic properties.
    Papoutsi Z, Kassi E, Mitakou S, Aligiannis N, Tsiapara A, Chrousos GP, Moutsatsou P.
    J Steroid Biochem Mol Biol; 2006 Jan; 98(1):63-71. PubMed ID: 16198557
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of estrogenic/antiestrogenic activity of Onobrychis ebenoides extract - interaction with estrogen receptor subtypes ERalpha and ERbeta.
    Papoutsi Z, Kassi E, Halabalaki M, Mitakou S, Moutsatsou P.
    Toxicol In Vitro; 2007 Apr; 21(3):364-70. PubMed ID: 17092687
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta.
    Papoutsi Z, Kassi E, Tsiapara A, Fokialakis N, Chrousos GP, Moutsatsou P.
    J Agric Food Chem; 2005 Oct 05; 53(20):7715-20. PubMed ID: 16190622
    [Abstract] [Full Text] [Related]

  • 4. Deoxybenzoins are novel potent selective estrogen receptor modulators.
    Papoutsi Z, Kassi E, Fokialakis N, Mitakou S, Lambrinidis G, Mikros E, Moutsatsou P.
    Steroids; 2007 Sep 05; 72(9-10):693-704. PubMed ID: 17659312
    [Abstract] [Full Text] [Related]

  • 5. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
    Guzmán CB, Deighton-Collins S, Martinez A, Kleerekoper M, Zhao C, Benjamins JA, Skafar DF.
    Neuro Endocrinol Lett; 2005 Oct 05; 26(5):526-32. PubMed ID: 16264406
    [Abstract] [Full Text] [Related]

  • 6. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
    Fadiel A, Song J, Tivon D, Hamza A, Cardozo T, Naftolin F.
    Reprod Sci; 2015 Feb 05; 22(2):146-55. PubMed ID: 25258361
    [Abstract] [Full Text] [Related]

  • 7. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A, Guo T, Lamminen E, Seppänen J, Kangas L, Väänänen HK, Härkönen P.
    Mol Cell Endocrinol; 2008 Jul 16; 289(1-2):38-48. PubMed ID: 18455292
    [Abstract] [Full Text] [Related]

  • 8. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 16; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 9. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.
    Mol Endocrinol; 2006 Dec 16; 20(12):3070-82. PubMed ID: 16901971
    [Abstract] [Full Text] [Related]

  • 10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 11. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2007 May 01; 104(3-5):110-22. PubMed ID: 17478088
    [Abstract] [Full Text] [Related]

  • 12. Anabolic effect of the traditional Chinese medicine compound tanshinone IIA on myotube hypertrophy is mediated by estrogen receptor.
    Zhao P, Soukup ST, Hegevoss J, Ngueu S, Kulling SE, Diel P.
    Planta Med; 2015 May 01; 81(7):578-85. PubMed ID: 26018796
    [Abstract] [Full Text] [Related]

  • 13. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA, Lee MK, Nam KH, Chung WY, Park CS, Lee JH, Noh T, Yang WI, Rhee Y, Lim SK, Lee HC, Lee EJ.
    J Endocrinol; 2007 Nov 01; 195(2):255-63. PubMed ID: 17951536
    [Abstract] [Full Text] [Related]

  • 14. Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation.
    Sreeja S, Santhosh Kumar TR, Lakshmi BS, Sreeja S.
    J Nutr Biochem; 2012 Jul 01; 23(7):725-32. PubMed ID: 21839626
    [Abstract] [Full Text] [Related]

  • 15. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP, Pezzuto JM.
    Cancer Res; 2001 Aug 15; 61(16):6137-44. PubMed ID: 11507064
    [Abstract] [Full Text] [Related]

  • 16. Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens.
    Margueron R, Duong V, Bonnet S, Escande A, Vignon F, Balaguer P, Cavaillès V.
    J Mol Endocrinol; 2004 Apr 15; 32(2):583-94. PubMed ID: 15072561
    [Abstract] [Full Text] [Related]

  • 17. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P, Sarrabayrouse G, Médale-Giamarchi C, Rochaix P, Balaguer P, Favre G, Faye JC, Doisneau-Sixou S.
    Breast Cancer Res; 2005 Apr 15; 7(1):R60-70. PubMed ID: 15642170
    [Abstract] [Full Text] [Related]

  • 18. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
    Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA.
    Mol Endocrinol; 1999 Mar 15; 13(3):418-30. PubMed ID: 10076999
    [Abstract] [Full Text] [Related]

  • 20. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA, Thompson LU.
    Breast Cancer Res Treat; 2003 Oct 15; 81(3):209-21. PubMed ID: 14620916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.